| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 143, Issue 3 923-930, Copyright © 1989 by American Association of Immunologists
ARTICLES |
JC Carel, B Frazier, TJ Ley and VM Holers
Howard Hughes Medical Institute Laboratories, Washington University, St. Louis, MO 63110.
We transfected human complement receptor 2 (CR2/CD21) cDNA containing eukaryotic expression constructs into CR2-negative mouse L cells and human K562 erythroleukemia cells. We subsequently selected stably transformed cells that expressed human CR2, as assessed by flow microfluorimetry analysis and immunoprecipitation of 125I-labeled surface membranes using the monoclonal anti-CR2 antibody, HB5. Utilizing flow microfluorimetry analysis, epitopes recognized by anti- CR2 mAb HB5, OKB7, B2, and four other anti-CR2 antibodies were detected on CR2 expressing transfectants but not parental cells. In addition, CR2 expressing transfected cells efficiently formed rosettes with sheep erythrocyte intermediates bearing human C3bi and C3d, but not C4b or C3b, consistent with the known ligand specificity of CR2. CR2 containing transfectants were also demonstrated to specifically bind EBV. Infection with EBV of CR2 expressing L cells and K562 cells resulted in mean expression of Epstein-Barr nuclear Ag (EBNA) at 48 h in 0.35% of CR2 expressing L cells and 3.7% of CR2 expressing K562 cells. Parental L cells and K562 cells did not express EBNA after EBV infection. These results indicate that CR2 alone is sufficient to transfer both C and EBV receptor functions to heterologous cells. In addition, expression of EBNA was found to be significantly higher in human K562 than mouse L cells, both expressing the same recombinant receptor. These results suggest that mechanisms other than CR2 binding lead to inefficient EBV infection and/or EBNA synthesis in mouse fibroblasts.
This article has been cited by other articles:
|
|
 |
|
  A. Aichem, M. Masilamani, and H. Illges Redox regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk J. Cell Sci., July 15, 2006; 119(14): 2892 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Marchbank, L. Kulik, M. G. Gipson, B. P. Morgan, and V. M. Holers Expression of Human Complement Receptor Type 2 (CD21) in Mice During Early B Cell Development Results in a Reduction in Mature B Cells and Hypogammaglobulinemia J. Immunol., October 1, 2002; 169(7): 3526 - 3535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Haan, A. Aiyar, and R. Longnecker Establishment of Latent Epstein-Barr Virus Infection and Stable Episomal Maintenance in Murine B-Cell Lines J. Virol., March 15, 2001; 75(6): 3016 - 3020. [Abstract] [Full Text]
|
|
|
|
|
|
A. Menet, C. Speth, C. Larcher, W. M. Prodinger, M. G. Schwendinger, P. Chan, M. Jäger, F. Schwarzmann, H. Recheis, M. Fontaine, et al. Epstein-Barr Virus Infection of Human Astrocyte Cell Lines J. Virol., September 1, 1999; 73(9): 7722 - 7733. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. R. Brink, K. Cronin, K. Banach, E. Peterson, E. M. Westphale, K. H. Seul, S. V. Ramanan, and E. C. Beyer Evidence for heteromeric gap junction channels formed from rat connexin43 and human connexin37 Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1386 - C1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Koval, J. E. Harley, E. Hick, and T. H. Steinberg Connexin46 Is Retained as Monomers in a trans-Golgi Compartment of Osteoblastic Cells J. Cell Biol., May 19, 1997; 137(4): 847 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Cao, G Lin, E. Westphale, E. Beyer, and T. Steinberg Mechanisms for the coordination of intercellular calcium signaling in insulin-secreting cells J. Cell Sci., January 2, 1997; 110(4): 497 - 504. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
